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Objectives . This study was conducted to investigate the presen-
tation and outcome of patients with Ebstein's anomaly of the
tricuspid valve .
Background. Ebstein's anomaly may present at any age and
has a highly variable clinical course . Previous natural history
studies have been based on clinical and angiographic diagnosis
and have included mainly older children and adults . Echocardi-
ography, however, has facilitated fetal and neonatal diagnosis so
that the natural history needs to be redefined .
Metho:lt. We reviewed 220 casesofEbstein's anomaly present-
ing front fetal to adult life between 1958 and 1991, with I to 34
years of follow-up.
Results. The most common presentation in each age group was
abnormal routine prenatal scan for fetuses (86%), cyanosis for
neonates (74%), heart failure for infants (43%), incidental mur-
mur for children (63%) and arrhythmia for adolescents and adults
(42%). Early presentation was frequently associated with other
cardiac lesions, usually pulmonary stenosis or atresia. Surgery
Ebstein's anomaly has an extremely variable natural history
(1-3) . It may present at any age, with a variety of hemo-
dynamic and electrophysiologic sequelae . If the deformity of
the tricuspid valve is severe, neonatal congestive heart
failure or even intrauterine death may occur (4,5) . In con-
trast, patients with isolated minor tricuspid valve displace-
ment may remain asymptomatic until late adult life (6) .
In the most recent (1974) large study (7) of the natural
history, <7% of 505 subjects were < I year old at diagnosis
(7). By failing to include patients who are now diagnosed by
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was undertaken at some s e in (39%) of the 220 patients .
Actuarial survival for all livebon patients was 67% at 1 year and
59% at 10 years. There were 58 deaths, including 26 from heart
failure, 19 perioperative and g sudden. Predictors of death
included echocardiographic grade of severity at presentation
(relative risk 2 .7 for each increase in grade, 95 % confidence limits
1 .6 to 4.6), fetal presentation (6 .9, confidence limits 1 .6 to 16 .5)
and right ventricular outflow tract obstruction (2 .1, confidence
limits 1 .1 to 4 .4). Morbidity was mainly related to arrhythmias
and late hemodynamic deterioration . Of 155 survivors, 129 (83%)
were in functional class I and 1 (67%) were receiving no
medical therapy .
Conclusions. In Ebstein's anomaly, fetal and neonatal presen-
tation is associated with a poor outcome and can be predicted by
the echocardi aphic appearance and presence of associated
lesions. In older children and adults, incidental findings and
arrhythmia s are common and the long-term outcome is superior .
(J Am Coll Cordial 1994,23:170-6?
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echocardiography in fetal or neonatal life, this and other
early natural history studies (8-10) have an inevitable bias
toward factors that favor survival . We therefore studied 220
cases of Ebstein's anomaly, presenting from fetal to adult
life and diagnosed between 1959 and 1991, to define the
pattern of presentation, outcome and factors predictive of
survival .
Methods
Subjects. Ebstein's anomaly was defined as any degree of
inferior displacement of the proximal attachments of the
tricuspid valve leaflets from the atrioventricular (AV) valve
ring (3) . All 220 patients with Ebstein's anomaly and con-
cordant cardiac connections identified from records of car-
diac catheterization, echocardiographic, electrophysiologic,
surgery, in-patient and necropsu data between 1958 and 1991
at five London hospitals (The Hospital for Sick Children
Great Ormond Street, The Royal Brompton National Heart
and Lung Hospital, Guy's Hospital, The Hammersmith
Hospital and St. Bartholomew's Hospital) were included .
Patients with variants such as those with an imperforate
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Table t . Major Presenting Feature off Ebstein's Anomaly in 220 Subjects
tricuspid valve or with AN' and ventriculoarterial discor-
dance ("corrected transposition") were excluded .
Case notes, chest X-ray films, 12-lead electrocardiograms
(ECGs), echocardiograms, surgical reports and autopsy data
were reviewed to confirm the diagnosis . Echocardiographic
grade of severity was `alculated for all 74 subjects in whom
an echocardiogram at presentation was available (5) . This
involved calculating the ratio of the combined area of the
right atrium and atrialized right ventricle to that of the
functional right ventricle and left heart in a four-chamber
view at end-diastole . This ratio is used to define four
grades of increasing severity
: ratio <00 = grade 1, ratio 0 .5
to 0.99 = grade 2, ratio I to I A9 f= grade 3 and ratio 2 :1 .5 =
grade 4
. Left ventricular function is difficult to quantify in
Ebstein's anomaly because most patients have paradoxic
motion of the ventricular septum . In this series, left ventric-
ular dysfunction was therefore defined as severely impaired
contraction of the left ventricular posterior wall on echocar-
diography or as global hypokinesia of the left ventricle on
anglography.
Investigations and management decisions were deter-
mined by the patient's cardiologist in each case . Antibiotic
prophylaxis against endocarditis was advised for all patients
.
"Junctional" tachycardia refers to AV or AV node reentrant
tachycandt .
Statistical methods. Kaplan-Meier survival curves for the
overall group and different clinical subgroups (antenatal,
ages 0 to 2, 2 to 18 and >18 years) were generated (11) .
Estimated posteonceptional age was used for survival curves
for fetal life ; for all other curves, postnatal age wii
., used .
When elective termination of pregnancy occurred, the fetus
was withdrawn alive from the analysis at that time . Patients
contributed to each analysis only from the time of referral to
our institutions ; this staggered entry is relevant when an
important proportion of patients present late . Multivariate
analysis was performed using only variables that could be
assessed at presentation and that were available for >50% of
subjects (presenting feature, associated defects, age at diag-
nosis, pre-excitation, era of diagnosis and chest X-ray film
but not echocardiographic grade) . Patients were censored at
death, whether "natural" or postoperative, and survival
beyond the last contact with our hospitals was not pre-
surned. Factors predictive of outcome were explored by
CELERMAJER FT AL .
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Age groups are : neonate = 0 to i month . infant = -2 years, child = tEdO years, adolescent = ~ 18 years and adult
>18 years (at time of prescritation) .
171
univariate and multivariate analysis using a Cox proportional
hazards model (12) . Relative risks are indicated with 95%
confidence limits . Proportions were compared using the




The age at presentation was 18 weeks' gestation to 68
years (median 36 days)
. There were 21 fetuses, 88 neonates
(0 to I month of age at presentation) . 23 infants ( :52 years),
50 children ( :5;10 years) . 15 adolescents ( :s18 years) and 23
adults (> 18 years) . Of the 220 subjects, 13 presented before
1960, 26 from 1961 to 1970, 45 from 1971 to 1980 and 122
from 1981 to 1990 (14 presented in 199t) . Them were 88 male
(409c') and 120 female (55%) subjects ; gender was not deter-
mined in 12 fetuses who died or were terminated before
birth . Follow-up ranged from 12 months to 34 years (median
6 years, >5 years in 125 subjects). Of 162 survivors, 133
(82%) had been seen within the last 2 years .
Presenting features. The mode of presentation differed
for each age group (Table 1) . In subjects <2 years old,
presentation with a hemodynamic problem was significantly
more common than in older patients (72% vs . 29%, p <
0.01), whereas presentation with an electrophysiologic prob-
lemm was more common in subjects >10 years of age (43% vs .
10%,p<0.01) .
Associated cardiac defects (other than a patent foramen
ovate or atrial septal defect) were present in 76 (35%) and
were more common in the younger age groups (8017c of
fetuses, 50% of neonates, 48% of infants, 14% of children
and 8% of adolescents and adults) (Fig . 1, Table 2) .
Investigations. On the chest X-ray film at presentation (in
171 of 208 postnatal cases), the cardiothoracic ratio was 40%
to 59% in 69 (40%), 60% to 89% in 99 (58%) and ?901`/c in 3
(2%). The 12-lead EGG revealed pre-excitation in 41 (20%)
.
In subjects without pre-excitation, a prolonged PR interval
was present in 34%, right atrial enlargement in 71% and
complete or incomplete right bundle branch block in 51%
. A
twodivonsisonal echocardiogram at presentation was avail-
able in 74 of 136 patients presenting since 1980 and showed
severity of grade I in 13 subjects (18%), grade 2 in 32 (43%),
















Cyanosis (I 6ti 1 83 03 ;
Heart failure 0 9 i0 4 2 6 31 04)
Incidental murrnui 0 8 1
33
5 3 52123)
Arrhythmia 1 S 1 6 6 10 29(13)
Abnormal fetal scan I 1, 0 0 0 0 0 13(8)
Other 2 1 1 0 0 3 7(3)
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Figure 1 . Associated defects in Ebstein's anomaly presenting at
different age groups . In fetal cases, functional and anatomic right
ventricular outflow tract obstruction (RVOTO) may be difficult to
distinguish and may be secondary to the tricuspid valve anomaly
(see text).
Cardiac catheterization was performed at some stage in
103 patients and was complicated by supraventricular or
ventricular tachyarrhythmia that was self-limited or respon-
sive to intravenous medication in 12 (12%) and complicated
by cardiopulmonary arrest in 7 (7%) . Of these seven pa-
tients, four died at catheterization (all before 1977) . Electro-
physiologic study was performed in 22 patients (18 with
drug-refractory arrhythmias, 2 with pre-excitation and syn-
cope and 2 with asymptomatic pre-excitation) . A total of 27
accessory connections were identified in 18 patients ; 10
patients had a single connection and 8 had multiple connec-
tions. Eleven accessory connections were in the right pos-
Table 2. Associated Cardiac Defects (other than patent foramen








*Eight subjects had mild Ebslein s anomaly with atrial seplal defect and
significant left to right shunt
. tAbsence of trabecular portion of the right
ventricle
. AVSU = atriovrntricular septal defect ; LV = left ventricular
;
MV = mitral valve
; PAIIVS = pulmonary atresia with intact ventricular
septum
; PDA = persistent ductus arteriosus
; RV = right ventricular ; VSD =
ventricular septal defect.
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Figure 2. Kaplan-Meier curve far observed survival of all liveborn
patients with Ebstein's anomaly . Broken tines indicate 95% confi-
dence intervals . Also shown is the estimated survival if patients are
all censored (withdrawn as alive) at the time of operation (most
optimistic case) and the survival if all patients had died at operation
(which most closely approximates the true "natural history" if
surgery is undertaken to prevent death) .
teroseptal region (41%), 10 in the right free wall (37%), 3 in
the left posteroseptal region, I in the left free wall and 2 were
of a Mahaim type .
Outcome . Of 220 patients, 58 (26%) died, 7 fetuses (3%)
were electively terminated and 155 patients (71%) were alive
at last follow-up. The actuarial survival rate was 67% at I
year (95% confidence limits [CL) 57% to 75%) and 59% at 10
years (95% CL 49% to 68%) (Fig. 2) . The annual hazard for
death was 36% for the Ist year of life, 4% for the 2nd year,
1 % from ages 2 to 10 years and 1 .4% from ages 10 to 40 years
(Fig. 3). In childhood, adolescence and adult life, there was
continuing attrition related to hemodynamic deterioration,
perioperative death and sudden unexpected death. Even
those who had presented with an incidentally detected
murmur had a small but continuing hazard for late death .
Predictors of outcome. Univariate analysis showed that a
significant risk of death was associated with echocardio-
graphic grade 4 (relative risk compared with grade I disease
13.3 ; 95% CL 1 .6 to 11l), cardiothoracic ratio >60% (rela-
tive risk 5.4; CL 1 .9 to 15), associated right ventricular
outflow tract obstruction (relative risk 2 .5; CL 1 .3 to 4 .8) and
presentation in fetal life (relative risk compared with child-
hood presentation 10.1 ; CL 2.3 to 44) . Of 21 fetuses, there
were 7 terminations (all with grade 3 or 4 disease), 5
intrauterine and 6 postnatal deaths and only 3 survivors, all
of whom had grade 2 disease at presentation (l-year survival
rate 15%). Pre-excitation and era at diagnosis were not risk
factors for death. When echocardiographic grade was
treated as a continuous variable, each incremental grade was
associated with a relative risk of 2 .7 (CL 1 .6 to 4.6). On
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Mg-dre 3 . Kaplan-Meier survival curves for
the fetal cases and the ages of 0 to 2, 2 to 18
and > 18 years (see Methods) . The x axis for
the Rol eases refers to estimated poqwn-
ceptional age ; for the other three survival
curves, the x axis refers to postnatal age .
2 - 18 pam
ated with fetal relative to childhood presentation (relative
risk 6 .9, CL 1 .6 to 16.5) and presence of right ventricular
outflow tract obstruction (relative risk 2 .1 CL 1 .1 to 4 .4) .
Surgery. The findings from 86 patients who underwent
surgical treatment are shown in Figure 4 . The indications for
operation wene persistent cyanosis or heart failure, or both,
in the neonate and hemodynamic : problems leading to func-
tional class III or IV symptoms or arrhythmias refractory to
drug treatment, or both, in older subjects .
Figure 4. Surgery for Ebstein's anomaly, Palliation in-
cludes aortopulmonary (n = 12) and cavopulmonary (n
= 2) shunts and pulmonary valvotomy (n = 12) .
"Closed" operation is any other procedure not involv-
ing cardiopulmonary bypass ; "open" operation does
involve bypass. Numbers in parentheses denote peri-
operative deaths in each group . ASD = atrial septal
defect ; EP = electrophysiologic ; OP = operation ; TV =
tricuspid valve . *Valve repair in 12 patients and valve
replacement in 20 . Three of these patients had electron
physiologic surgery with their tricuspid valve operation,
one of whom died perioperatively. "Includes two pa-
tients with ventricular septal defect closure, one with
repair of tetralogy of Fallot and one with a Fontan-type
repair .
CELERMMER ET AL .







In the 32 patients who had tricuspid valve surgery (at age
8 days to 46 years), the risk was more related to ge at
presentation than to age at operation . The perioperative
mortality rate was 50% (8 of 16 patients) for those whose
condition was diagnosed in the 1st year of life (13 of whom
were operated on after infancy) and 0% for the 16 patients
whose condition was diagnosed after age 1 year (p < O .OW 11) .
Seventeen patients had a second operation and two required
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Morbidity . Twenty-eight neonates with initial resolution
of neonatal cyanosis later developed heart failure or cyano-
sis, or both (2 to 18 years after initial presentation) ; I I of
these had evidence of left ventricular dysfunction . Of 220
patients, 74 (34%) have had arrhythmias at some stage and
13 others have pre-excitation but no symptoms to date . The
most common arrhythmias were junctional tachyrardia (43
patients), atriall flutter or fibrillation (28 patients) and ven-
tricular tachycardia (15 patients); several patients had more
than one type of arrhythmia documented . Supraventricular
arrhythmias tended to be recurrent and drug refractory, with
42 (57%) of 74 patients requiring two or more antiarrhythrnic
medications to achieve symptomatic control . Bradyarrhytha
mia was less common ; AV block occurred in five patients (in
relation to surgery in two and to cardiac catheterization in
three) .
There were two cases of paradoxic embolism, both caus-
ing hemiparesis in young adults who had been in sinus
rhythm ; one child had a cerebral abscess . The only case of
documented endocarditis affected the tricuspid valve of a
62-year old man who died of progressive tricuspid regurgi-
tation.
Mortality . Death was due to congestive heart failure in 26
(45%) of 58 patients, was perioperative in 19 (33%), sudden
and unexpected in 8 (14%), related to cardiac catheterizatun
in 4 and of noncardiac origin in one child . The deaths from
heart failure occurred in neonates managed conservatively
(I I patients, all before 1980), children who were initially well
but developed late hemodynamic problems (13 patients,
associated with left ventricular dysfunction in 8 and with
progressive tricuspid valve dysfunction, right heart dilation
or atrial fibrillation in 5) and 2 older adults (I with severe
disease considered inoperable and the other with tricuspid
valve endocarditis) . Of the eight patients who died suddenly,
four had previously documented arrhythmias (atrial flutter or
fibrillation late after tricuspid valve surgery in three, ventric-
ular tachycardia in one), one had had recent symptomatic
deterioration and three had no antecedent event that could
be identified. No patient who died suddenly had pre-
excitation .
Survivors . Of the 155 survivors, 129 (83%) were in func-
tional class 1, 23 (159%) in class II, 3 (2%) in class III and none
in class IV when last assessed . Most survivors were receiv-
ing no medical therapy (104 (67%) of 155 patients ; 20 were
receiving digoxin only, 9 were receiving digoxin and diuretic
drugs and 22 were receiving another antiarrhythmic agent) .
Discussion
This study has shown that fetuses, neonates and infants
with Ebstein's anomaly usually present with hemodynamic
sequelae of severe tricuspid valve displacement and right
ventricular abnormalities and have a poor prognosis . There
is an early death hazard due to heart failure and intrauterine
cardiomegaly causing pulmonary hypoplasia (13) and a con-
tinuing later hazard due to hemodynamic deterioration in
JACC Vol. 23, No . I
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childhood or adolescence, perioperative death or sudden
death. In contrast, childhood Ebstein's anomaly usually
presents with an incidental murmur, and the outlook ;s good .
The main clinical problem for adolescents and adults with
Ebstein's anomaly is arrhythmia . This may be due to the
natural history of pre-excitation, progressive atrial dilation
or the association of both .
Associated cardiac defects were common in patients
presenting early (Fig . 1). In fetal life, functional and ana-
tomic right ventricular outflow obstruction are di cult to
distinguish (14), and severe tricuspid regurgitation may
simulate pulmonary atresia (15) . Structural pulmonary valve
abnormalities are most likely secondary to the tricuspid
valve anomaly (I1), resulting from low anterograde flow
during outflow tract development (161 .
The true "natural history" of Ebstein's anomaly cannot
be determined because many patients underwent surgical
treatment . Survival data have therefore been presented in
three ways (Fig . 2) : the observed survival, the most optimis-
tic case (patients withdrawn as alive at time of operation)
and the worst case (patients withdrawn as dead at time of
operation) . The true natural history lies between the ob-
served and worst case curves, but probably closer to the
latter because patients in our series were usually operated on
when they were severely symptomatic .
Limitations of study . This study included all 220 patients
referred to five London teaching hospitals over a 30-year
period, even those with minor tricuspid valve displacement
and those with serious associated defects. This confirms the
relative rarity of this condition . The majority of children with
hemodynamic problems, unexplained murmurs and arrhyth-
mias from Southeast England and most adults with cyanosis
or arrhythmias would have been referred to one of these
hospitals over the duration of the study. The proportion of
patients with undiagnosed Ebstein's anomaly has probably
changed over the study period . Some patients will have died
without a diagnosis and others will be alive with as yet
unrecognized Ebstein's anomaly; the net effect of such
patients on the survival curves presented in this report is
uncertain.
The median age at presentation was <I year, underscor-
ing the impact of echocardiography on the diagnosis of
congenital heart disease in fetuses and infants and the
change in pattern of referrals for Ebstein's anomaly in the
last decade . These data, however, reflect only the medical
practice at our institutions over a particular time frame,
which has evolved during the period of the study . Important
potential sources of bias also exist as a result of the inevita-
ble individualization of the timing and type of investigations
and treatment .
Morbidity and mortality . Endocarditis was rare in this
series, with only one case documented in >1,000 patient-
years of follow-up. Although the "natural" risk of valve
infection cannot be determined, there is a low risk if antibi-
otic prophylaxis is recommended . Paradoxic embolism was
also rare, and we do not routinely undertake anticoagulant
JACC Vol . 23, No . 7
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therapy in patients it sinus rhythm . Arrhythmias were
common particularly in the older age groups and were
usually related to accessory AV connections and atrial
flutter or fibrillation . These arrhvthmias tended to be recur-
rent and resistant to drug treatment (M . Catheter ablation
for accessory connections has not been performed often in
Ebstein's anomaly and is difficult because most connections
are right-sided, the right atrium is large and the anatomy of
the right AV rip-,
is
distorted . Arrhythmia surgery is feasible,
and both short- and long-term results are good for appropri-
ately selected cases (18). Some cases of late sudden death
may be related to arrhythmias ; however, it is not known
whether routine noninvasive or invasive electrophysiologic
testing or treatment of any detected arrhythrias will mini-
mize the risk of this complication .
Late hemodynamic deterioration may be due to increased
right to left shunting and right or left heart failure, or both .
The incidence of late left ventricular dysfunction cannot be
estimated from this study because serial measurements were
not routinely perforated . Furthermore, left veu1ricuial dys-
function is especially difficult to assess in Ebstein's anomaly
because of paradoxic septal motion, which inihaenees the
estimation of ejection fraction and fractional shortening . The
true incidence of left ventricular dysfunction is probably
underestimated because only patients with very poor poste-
rior wall contraction were included .
The association between Ebstein's anomaly and left
ventricular abnormalities has been previously noted `19,20),
and Saxena et al . (21) have recently documented unsus-
pected abnormalities in left ventricular function and limita-
tion in exercise capacity in mildly symptomatic adults .
Exercise testing may therefore be useful in assessing cardiac
performance, given the limitations of echocardiographic
indexes. The cause of left ventricular dysfunction is unclear,
but may be due to chronic cyanosis, right heart dilation and
septal abnormalities (22) and increased left ventricular fibro-
sis (16) .
Management. Echocardiography is the most important
diagnostic test in Ebstein's anomaly, permitting accurate
assessment of the anatomy and distal attachments of the
tricuspid valve, the size and contractility of the functional
right ventricle and the overall grade of disease severity .
Cardiac catheterization is rarely required, other than for
electrophysiologic study or for investigation of associated
cardiac defects .
Neonates . Newborns with isolated Ebstein's anomaly
and cyanosis usually show spontaneous improvement as
pulmonary vascular resistance decreases (13) .
Those in
whom persistent cyanosis is due to associated right ventric-
ular outflow obstruction do well after surgical palliation if
their Ebstein's anomaly is not severe (echocardiographic
grade I or 2). The results of tricuspid valve surgery were
poor, however, for neonates and infants with symptomatic
heart failure and severe Ebstein's anomaly, and this proba-
bly reflects more severe disease requiring intervention in
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creation of functional tricuspid atresia (by closing the tricus-
pid valve and excising the atrial septum) with insertion of a
systemic to pulmonary artery shunt (24), with a view to later
Fontan-type surgery, or heart transplantation (25) .
Older children and adults, In this group the most com-
men indication for tricuspid valve surgery was worsening
congestive heart failure . Operations early in this series were
usually valve replacement, but valve repair has been under-
taken where possible since the reports of excellent periop-
erative results in highly selected patients by fair et al . (26),
who described creation of a monocusp valve and transverse
plication of the atrialized right ventricle, and by Carpentier
et al . (27), who described longitudinal plication .
In patients whose heart failure is due to increasing
tricuspid regurgitation and right atrial enlargement, tricuspid
valve surgery should improve symptomatic status . In many
of our patients with late hemodynamic deterioration, how-
ever, there was evidence of poor left ventricular function ; in
these patients, tricuspid valve surgery may not necessarily
improve functional status or long-term outco e . Prospective
study is required to determine whether serial measurement
of echocardiographic grade of disease severity, left ventric-
ular function or exercise tolerance might predict symptom-
atic deterioration and the need for surgery .
Some investigators (29) have suggested on the basis of
retrospective data that tricuspid valve surgery is indicated
for asymptomatic patients with a cardiothoracic ratio X65%
because this may be a better predictor than functional status
of late sudden death . In our series, sudden death was rare in
patients who did not undergo operation, even in those with
cardiomegaly . Furthermore, sudden death may occur in
patients with mild disease and a normal heart size on the
chest X-ray film (29) . Because surgery carries a significant
risk, even in older children and adults, and there is no
evidence to date that it reduces the hazard for sudden death,
we do not currently perform tricuspid valve surgery in
asymptomatic patients .
Clinical implications . The management of Ebstein's
anomaly therefore depends on the age at presentation,
anatomic severity of the lesion, presence of associated
defects and clinical features . Fetal Ebstein's anomaly has an
appalling outlook, and prenatal counseling should take this
into account . Grade I or 2 disease in neonates and infants
has a good outcome and palliation should be undertaken for
associated lesions, but grade 3 or 4 disease in young children
has a poor prognosis. Older children and adults can be
managed medically until symptoms appear, when good re-
sults may be obtained by valve surgery, particularly valve
repair . In all age groups, however, there is an increasing risk
of arrhythmias (17) and a persistent risk of late hemody-
namic deterioration and sudden death .
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